Physician profile
Eugene Wang
NPI 1912223108
$21,740.95
in general payments reported to CMS, 2019-2025
54 companies · $3,351 in 2025
The $3,351 reported for 2025 was more than what 82% of Pain Medicine (Psychiatry & Neurology) providers received nationally (typical 2025 total: $405).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,627 · 2020: $701 · 2021: $1,648 · 2022: $1,608 · 2023: $5,294 · 2024: $7,513 · 2025: $3,351.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $10K · Travel and Lodging: $5,443 · Consulting Fee: $375 · Education: $27.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,312.62 |
| Travel and Lodging | $5,443.03 |
| Consulting Fee | $375.00 |
| Education | $27.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $7,250.19 | 2022-2025 | Intellis Adaptivestim, Inceptiv, Accurian |
| Boston Scientific Corporation | $2,210.33 | 2019-2025 | Intracept |
| Relievant Medsystems, INC. | $1,624.43 | 2022-2023 | Intracept |
| Nevro Corp. | $1,481.57 | 2019-2024 | Senza |
| Biotronik Nro, INC. | $1,397.01 | 2025 | Prospera |
| Abbvie INC. | $1,207.12 | 2021-2025 | Ubrelvy, Qulipta, Botox |
| Nalu Medical, INC. | $849.74 | 2022-2024 | Nalu Neurostimulation System |
| Abbott Laboratories | $739.73 | 2019-2025 | Proclaim |
| Bioventus LLC | $652.48 | 2024-2025 | Stimrouter Implantable Kit |
| Allergan, INC. | $427.35 | 2019-2022 | |
| Stryker Corporation | $391.93 | 2023-2025 | Omnicurve |
| Vertos Medical, INC. | $318.28 | 2023-2024 | Mild Device Kit |
| Painteq LLC | $261.21 | 2023-2024 | Painteq |
| Scilex Pharmaceuticals INC. | $247.95 | 2021-2024 | Ztlido |
| Spr Therapeutics, INC | $202.59 | 2023-2024 | Sprint Pns System |
Show all 54 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eugene Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.